The largest database of trusted experimental protocols

P3 nucleofection solution

Manufactured by Lonza

The P3 nucleofection solution is a reagent used in the nucleofection process, a non-viral method for introducing nucleic acids, such as DNA or RNA, into cells. It is designed to facilitate the delivery and uptake of these molecules into the cell nucleus. The P3 solution is a key component of the nucleofection technology and is used in conjunction with Lonza's proprietary nucleofector devices and protocols.

Automatically generated - may contain errors

6 protocols using p3 nucleofection solution

1

CRISPR-Cas9 Editing of Primary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Editing of all primary cells was carried out using a ribonucleic protein (RNP) system at a molar ratio of either 1:2.5 or 1:5 (Cas9: sgRNA), unless otherwise stated. Recombinant S. pyogenes Cas9 protein was purchased from IDT (Integrated DNA Technologies, Coralville, Iowa, USA). Nucleofection was performed in P3 nucleofection solution (Lonza) and Lonza Nucleofector 4d (program DZ-100). Cells were plated at a concentration of 1.0 × 105–2.5 × 105 cells/ml. For T cells editing, electroporation was performed using Lonza Nucleofector 4d (program EO-115) with an RNP composition as used for CD34+ HSPCs editing. INDEL frequencies were quantified using TIDE online software on genomic DNA extracted using Quick Extract (Epicentre, an Illumina Company, cat no. QE09050) according to manufacturing specifications.
+ Open protocol
+ Expand
2

Transposon-free iPSC Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
iRhpb#4 in feeder-free conditions was nucleofected using 4D-nucleofector device (Lonza). 1 × 106 cells were transfected with pBase-tdTomato transposase vector (6 µg), using P3 nucleofection solution and program CA-137 (Lonza). UPPS medium was supplemented for 2 days with PSF (5 µM) after transfection. After 3 days Tomato positive clones were sorted using SH800S Cell Sorter (Sony Biotechnology), sorting 10 cells per well in a 24 well plate. Potential transgene-free colonies were picked and expanded for 2–5 passages. Colonies were then pelleted and gDNA was extracted. Detection PCR was performed using primers specifically designed to detect different regions of the transposon (Supplementary Table 1). PCR was performed using Taq DNA polymerase with Standard Taq Buffer (New England BioLabs) according to manufacturer instructions. Original gel electrophoresis pictures of PCR analysis can be found in Supplementary Fig. 14. Transgene-free clones were checked for the absence of the reprogramming construct every 10 passages.
Transfection efficiency was evaluated 3 days after transfection by FACS sorting. The analysis was performed in triplicates for two iPSC lines in feeder-free conditions (iRhpb#2 and 4). 10 × 103 events were recorded for the analysis of each sample.
+ Open protocol
+ Expand
3

Efficient CRISPR-Cas9 Knockout of Regnase-1 and Roquin-1 in T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-guide RNA (sgRNA) sequences targeting Regnase-1 and Roquin-1 were designed using Benchling online software (https://www.benchling.com) and cross-validated with Synthego’s guide design verification tool (https://design.synthego.com/#/validate). sgRNA sequences were synthesized by Integrated DNA Technologies (IDT). After screening several (3+) sgRNAs targeting each gene (SI Appendix, Table S1), the top sgRNA was selected for downstream experiments. Gene disruption was performed following an optimized protocol previously described (33 ). Briefly, T cells were washed three times in Opti-MEM™ reduced serum medium (Gibco) and resuspended at 1 × 108 cells/mL in P3 nucleofection solution (Lonza). Ribonucleoprotein (RNP) complexes were generated by incubating each sgRNA (5 μg per 10 × 106 cells) individually with Cas9 nuclease (Aldevron, 10 μg per 10 × 106 cells) for 10 min at room temperature. For no knockout (Mock) groups, no sgRNA was used and for multiple knockout groups, RNPs targeting each gene were incubated separately before combining. Cells were electroporated in batches of 10 × 106 cells (100 µL) with a mixture of RNP complex and 16.8 pmol of electroporation enhancer (IDT) in electroporation cuvettes (electroporation code EH111) in a 4D-Nucleofector X-Unit (Lonza).
+ Open protocol
+ Expand
4

CRISPR Knockout of ZFP36 in T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single guide RNA (sgRNA) sequences targeting the ZFP36 genomic locus were designed using Benchling online software (https://www.benchling.com) and cross-validated with Synthego’s guide design verification tool (https://design.synthego.com/#/validate). sgRNA sequences were synthesized by Integrated DNA Technologies (IDT). After screening three sgRNAs against ZFP36, the top sgRNA was selected for downstream experiments (sgRNA sequence: 5′-CGCTCCACCAGCCTAGTGGA-3′). Gene disruption was performed following an optimized protocol previously described19 (link). Briefly, T cells were washed three times in Opti-MEM™ reduced serum medium (Gibco) and resuspended at 1 × 108 cells/mL in P3 nucleofection solution (Lonza). Ribonucleoprotein (RNP) complexes were generated by incubating each sgRNA (5ug per 10 × 106 cells) individually with Cas9 nuclease (Aldevron, 10ug per 10 × 106 cells) for 10 min at room temperature. For mock groups, no sgRNA was used and for multiple knockout groups, RNPs targeting each gene were incubated separately before combining. Cells were electroporated in batches of 10 × 106 cells (100 µL) with a mixture of RNP complex and 16.8 pmol of electroporation enhancer (IDT) in electroporation cuvettes (electroporation code EH111) in a 4D-Nucleofector X-Unit (Lonza).
+ Open protocol
+ Expand
5

CRISPR-Mediated Monocyte Gene Editing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells (PBMCs) from de-identified
donors were obtained from AllCells (Alameda, CA, USA) under donor-informed
consent and Alpha IRB approval obtained by AllCells (7000-SOP-045) for the study
“Non-Mobilized Mononuclear Cell Apheresis Collection from Healthy Donors
for the Research Market”. Monocytes were isolated by negative selection
(Pan Monocyte Isolation Kit, Miltenyi Biotec) and nucleofected with Cas9:gRNA
ribonucleoparticles as previously described57 (link). Alt-R crRNAs and Alt-tracrRNA (IDT) were resuspended
to 100 μM in nuclease-free duplex buffer (IDT) and annealed at equimolar
concentrations for 5 min at 95°C and 15 min at 20°C. 10 μg
Cas9 (IDT Alt-R S.p. Cas9 Nuclease V3) was mixed with 2 μl of the
crRNA:tracrRNA complex and incubated for 20 min at room temperature before 1
μl of a 4 μM solution of electroporation enhancer (IDT) in
nuclease-free duplex buffer (IDT) was added. 1e6 monocytes in 20 μl P3
nucleofection solution (Lonza) were added to the Cas9:crRNA:tracrRNA complex and
nucleofected with a Lonza 4D-Nucleofector (4D-Nucleofector Core Unit,
4D-Nucleofector X Unit) using the settings Buffer P3, CM-137. Cells were
immediately resuspended in pre-warmed medium and cultivated for 5 days. Every
other day half of the medium was replaced with fresh medium.
crRNA target sites:
MORC3GCTGATACTGAGATACCATATGG
scrambleGCTGCTCCCTAACAGGACGC
+ Open protocol
+ Expand
6

T Cell Isolation, Activation, and Genetic Modification

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were isolated from donor leukopaks (STEMCELL Technologies) by negative selection with CD3 magnetic beads (EasySep Human T Cell Isolation Kit; STEMCELL Technologies) according to the manufacturer’s protocol and frozen in LN2 at 20x106 cells/mL for storage. Donor T cells were then thawed, washed twice in X-VIVO 15 media (Lonza) then resuspended at 1x106 cells/mL in T cell medium (X-VIVO 15 supplemented with 5% FBS, 55 μM 2-mercaptoethanol and 200 IU/mL recombinant human IL2) prior to the addition of CD3/CD28 conjugated magnetic activation beads (Dynabeads; Invitrogen) at a 1:1 bead-to-cell ratio. Forty-eight hours later the cells were washed 1x in PBS, resuspended in 20 μL of supplemented P3 nucleofection solution (Lonza) at 50x106 cells/mL, and immediately added to the RNPs and mixed by gentle pipetting. The cell/RNP mixture was placed in one well of a 16-well cuvette strip (P3 Primary Cell 4D-Nucleofector X Kit S; Lonza) and electroporated using program EH115 on a Lonza X-Unit nucleofector. Immediately after, 100 μL of warm X-VIVO+5% FBS was added to the well, and the cells were placed in a 5% CO2 incubator at 37°C for 15 min, then plated in 4 mL of T cell medium. Cells were monitored daily and split 1:1 when the density reached 2x106 cells/mL or media showed signs of acidification.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!